BATTISTINI STEFANIA
Curriculum Vitae
Teaching activities
Completion accademic year: 2025/2026
Course year: 2
First cycle degree (DM 270)
ENVIRONMENT AND WORKPLACE PREVENTION TECHNIQUES
A.Y. 2024/2025
Completion accademic year: 2024/2025
Course year: 2
First cycle degree (DM 270)
ENVIRONMENT AND WORKPLACE PREVENTION TECHNIQUES
A.Y. 2023/2024
Completion accademic year: 2023/2024
Course year: 2
First cycle degree (DM 270)
ENVIRONMENT AND WORKPLACE PREVENTION TECHNIQUES
A.Y. 2022/2023
Research
Ultime pubblicazioni:
- Iannone, L.F., Vaghi, G., Sebastianelli, G., Casillo, F., Russo, A., Silvestro, M., et al. (2025). Effectiveness and tolerability of rimegepant in the acute treatment of migraine: a real-world, prospective, multicentric study (GAINER study). THE JOURNAL OF HEADACHE AND PAIN, 26(1) [10.1186/s10194-024-01935-8]. - view more
- Saez-Atienzar, S., Souza, C.d.S., Chia, R., Beal, S.N., Lorenzini, I., Huang, R., et al. (2024). Mechanism-free repurposing of drugs for C9orf72-related ALS/FTD using large-scale genomic data. CELL GENOMICS, 4(11) [10.1016/j.xgen.2024.100679]. - view more
- Caponnetto, V., Russo, A., Silvestro, M., Tessitore, A., De Icco, R., Vaghi, G., et al. (2023). Long-term treatment over 52 weeks with monthly fremanezumab in drug-resistant migraine: a prospective multicenter cohort study. CNS DRUGS, 37(12), 1069-1080 [10.1007/s40263-023-01050-3]. - view more
- Canosa, A., Calvo, A., Mora, G., Moglia, C., Brunetti, M., Barberis, M., et al. (2023). The HFE p.H63D (p.His63Asp) Polymorphism Is a Modifier of ALS Outcome in Italian and French Patients with SOD1 Mutations. BIOMEDICINES, 11(3), 1-8 [10.3390/biomedicines11030704]. - view more
- Riolo, G., Ricci, C., De Angelis, N., Marzocchi, C., Guerrera, G., Borsellino, G., et al. (2022). BDNF and Pro-BDNF in Amyotrophic Lateral Sclerosis: A New Perspective for Biomarkers of Neurodegeneration. BRAIN SCIENCES, 12(5), 1-15 [10.3390/brainsci12050617]. - view more